Cannabis Bioscience International Holdings (CBIH) Debt to Equity (2023 - 2025)
Historic Debt to Equity for Cannabis Bioscience International Holdings (CBIH) over the last 3 years, with Q3 2025 value amounting to -$0.21.
- Cannabis Bioscience International Holdings' Debt to Equity rose 1283.1% to -$0.21 in Q3 2025 from the same period last year, while for Aug 2025 it was -$0.21, marking a year-over-year increase of 1283.1%. This contributed to the annual value of -$0.24 for FY2025, which is 83.54% down from last year.
- Latest data reveals that Cannabis Bioscience International Holdings reported Debt to Equity of -$0.21 as of Q3 2025, which was up 1283.1% from -$0.24 recorded in Q2 2025.
- In the past 5 years, Cannabis Bioscience International Holdings' Debt to Equity ranged from a high of -$0.21 in Q3 2025 and a low of -$0.45 during Q2 2023
- In the last 3 years, Cannabis Bioscience International Holdings' Debt to Equity had a median value of -$0.24 in 2024 and averaged -$0.27.
- Per our database at Business Quant, Cannabis Bioscience International Holdings' Debt to Equity skyrocketed by 4676.01% in 2024 and then tumbled by 83.54% in 2025.
- Over the past 3 years, Cannabis Bioscience International Holdings' Debt to Equity (Quarter) stood at -$0.31 in 2023, then grew by 27.03% to -$0.23 in 2024, then rose by 6.53% to -$0.21 in 2025.
- Its Debt to Equity stands at -$0.21 for Q3 2025, versus -$0.24 for Q2 2025 and -$0.26 for Q1 2025.